PTGS2 and atherosclerosis: For example, PPARα inhibits expression of IL-6, prostaglandin, and cyclooxygenase-2 (COX-2) via repression of NF-κB signaling in aortic smooth muscle cells, thus possibly reducing the risk for atherosclerosis [62].